Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

Belshe RB, Stevens C, Gorse GJ, Buchbinder S, Weinhold K, Sheppard H, Stablein D, Self S, McNamara J, Frey S, Flores J, Excler JL, Klein M, Habib RE, Duliege AM, Harro C, Corey L, Keefer M, Mulligan M, Wright P, Celum C, Judson F, Mayer K, McKirnan D, Marmor M, Woody G; National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET).

J Infect Dis. 2001 May 1;183(9):1343-52. Epub 2001 Apr 10.

PMID:
11294665
2.

Development of a DNA-MVA/HIVA vaccine for Kenya.

Hanke T, McMichael AJ, Mwau M, Wee EG, Ceberej I, Patel S, Sutton J, Tomlinson M, Samuel RV.

Vaccine. 2002 May 6;20(15):1995-8. Review.

PMID:
11983261
3.

Vaccines and vaccine strategies against HIV.

Stratov I, DeRose R, Purcell DF, Kent SJ.

Curr Drug Targets. 2004 Jan;5(1):71-88. Review.

PMID:
14738219
4.

Progress in the development of an HIV-1 vaccine.

Letvin NL.

Science. 1998 Jun 19;280(5371):1875-80. Review.

PMID:
9632379
5.

Poxvirus vector-based HIV vaccines.

Pantaleo G, Esteban M, Jacobs B, Tartaglia J.

Curr Opin HIV AIDS. 2010 Sep;5(5):391-6. doi: 10.1097/COH.0b013e32833d1e87. Review.

PMID:
20978379
6.

[The quest for an HIV vaccine].

Girard MP.

Bull Acad Natl Med. 2005 May;189(5):831-44; discussion 844. Review. French.

PMID:
16433455
7.

Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors.

Franchini G, Gurunathan S, Baglyos L, Plotkin S, Tartaglia J.

Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S75-88. Review.

PMID:
15285707
8.

Expression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine.

Hone DM, Lewis GK, Beier M, Harris A, McDaniels T, Fouts TR.

Dev Biol Stand. 1994;82:159-62. Review.

PMID:
7958470
9.

[Development of HIV vaccines].

Shibata R.

Nihon Rinsho. 2002 Apr;60(4):790-7. Review. Japanese.

PMID:
11968790
10.

[HIV vaccine trials].

Ikuta K.

Hokkaido Igaku Zasshi. 1993 Sep;68(5):603-8. Review. Japanese.

PMID:
8225164
11.

Development of bivalent rgp120 vaccines to prevent HIV type 1 infection.

Berman PW.

AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S277-89. Review.

PMID:
9814956
12.

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.

Francis DP, Gregory T, McElrath MJ, Belshe RB, Gorse GJ, Migasena S, Kitayaporn D, Pitisuttitham P, Matthews T, Schwartz DH, Berman PW.

AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S325-31. Review.

PMID:
9814961
13.

Idiotypic cascades associated with the CD4-HIV gp120 interaction: principles for idiotype-based vaccines.

Attanasio R, Kennedy RC.

Int Rev Immunol. 1990;7(1):109-19. Review.

PMID:
1722497
14.

HIV vaccines in infants and children.

Lambert JS.

Paediatr Drugs. 2005;7(5):267-76. Review.

PMID:
16220994
15.

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.

Girard MP, Osmanov S, Assossou OM, Kieny MP.

Vaccine. 2011 Aug 26;29(37):6191-218. doi: 10.1016/j.vaccine.2011.06.085. Epub 2011 Jun 28. Review.

PMID:
21718747
16.

Assessment of HIV vaccine development: past, present, and future.

Cho MW.

Adv Pharmacol. 2000;49:263-314. Review. No abstract available.

PMID:
11013767
17.

Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV.

Vaccari M, Poonam P, Franchini G.

Expert Rev Vaccines. 2010 Sep;9(9):997-1005. doi: 10.1586/erv.10.104. Review.

PMID:
20822342
18.
19.

Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccines.

Hung PP, Chanda PK, Natuk RJ, Mason BB, Chengalvala M, Bhat BM, Molnar-Kimber KL, Dheer SK, Morin JE, Mizutani S, et al.

Nat Immun Cell Growth Regul. 1990;9(3):160-4. Review.

PMID:
2196459
20.

Canarypox virus-based vaccines: prime-boost strategies to induce cell-mediated and humoral immunity against HIV.

Tartaglia J, Excler JL, El Habib R, Limbach K, Meignier B, Plotkin S, Klein M.

AIDS Res Hum Retroviruses. 1998 Oct;14 Suppl 3:S291-8. Review. No abstract available.

PMID:
9814957

Supplemental Content

Support Center